Daniel G Tenen Selected Research

Daniel G Tenen Research Topics

Disease

55	Neoplasms (Cancer) 03/2024 - 01/2002
42	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 01/2002
34	Leukemia 10/2021 - 02/2003
19	Lung Neoplasms (Lung Cancer) 06/2023 - 01/2002
16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2019 - 01/2005
7	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2021 - 11/2003
6	Hepatocellular Carcinoma (Hepatoma) 12/2019 - 09/2011
6	Myeloid Leukemia (Leukemia, Myelocytic) 01/2019 - 01/2003
4	Carcinogenesis 07/2023 - 02/2006
4	Acute Promyelocytic Leukemia 08/2015 - 11/2003
4	Genetic Translocation (Chromosomal Translocation) 09/2014 - 02/2003
3	Breast Neoplasms (Breast Cancer) 10/2022 - 07/2010
3	Adenocarcinoma 01/2021 - 07/2010
3	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 06/2006
3	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2019 - 12/2017
2	Alzheimer Disease (Alzheimer's Disease) 11/2023 - 08/2004
2	Liver Neoplasms (Liver Cancer) 01/2021 - 09/2011
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019 - 12/2017
2	Blast Crisis (Blast Phase) 09/2015 - 05/2006
2	Hematologic Neoplasms (Hematological Malignancy) 10/2014 - 02/2009
1	Triple Negative Breast Neoplasms 10/2022
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022
1	Hematologic Diseases (Blood Diseases) 10/2021
1	Cognitive Dysfunction 01/2021
1	Dementia (Dementias) 01/2021
1	COVID-19 10/2020
1	Critical Illness (Critically Ill) 10/2020
1	Neoplasm Metastasis (Metastasis) 01/2020

Drug/Important Bio-Agent (IBA)

39	Transcription Factors (Transcription Factor)IBA 01/2024 - 01/2002
28	Proteins (Proteins, Gene)FDA Link 07/2023 - 01/2002
23	CCAAT-Enhancer-Binding Protein-alphaIBA 12/2010 - 01/2002
13	ErbB Receptors (EGF Receptor)IBA 01/2018 - 01/2005
11	RNA (Ribonucleic Acid)IBA 01/2023 - 02/2013
11	Tyrosine Kinase InhibitorsIBA 12/2021 - 08/2005
11	Gefitinib (Iressa)FDA Link 07/2010 - 01/2005
9	CCAAT-Enhancer-Binding ProteinsIBA 01/2019 - 02/2003
7	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2010 - 08/2005
6	MicroRNAs (MicroRNA)IBA 12/2021 - 09/2011
6	ChromatinIBA 10/2021 - 10/2014
6	proto-oncogene protein Spi-1IBA 08/2008 - 01/2003
4	Peptides (Polypeptides)IBA 01/2018 - 10/2007
4	promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA 02/2008 - 02/2003
4	Retinoic Acid Receptor alphaIBA 10/2006 - 02/2003
3	Adenosine (Adenocard)FDA LinkGeneric 01/2023 - 05/2014
3	Core Binding Factors (Core-Binding Factor)IBA 01/2023 - 03/2014
3	EnzymesIBA 01/2023 - 07/2008
3	Long Noncoding RNAIBA 10/2022 - 10/2018
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 07/2003
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 08/2015 - 11/2003
3	ElementsIBA 03/2011 - 01/2006
2	Immunomodulating AgentsIBA 01/2024 - 07/2023
2	Protein Isoforms (Isoforms)IBA 07/2023 - 11/2007
2	Lysine (L-Lysine)FDA Link 06/2023 - 01/2021
2	Messenger RNA (mRNA)IBA 06/2023 - 07/2012
2	Inosine FDA Link 01/2023 - 01/2018
2	entinostat (MS 275)IBA 12/2021 - 11/2016
2	Histones (Histone)IBA 01/2021 - 01/2017
2	T-Cell Acute Lymphocytic Leukemia Protein 1IBA 01/2019 - 12/2017
2	coactivator-associated arginine methyltransferase 1IBA 11/2018 - 07/2010
2	Histone Deacetylase InhibitorsIBA 11/2016 - 04/2014
2	CytokinesIBA 05/2015 - 07/2006
2	Biomarkers (Surrogate Marker)IBA 10/2013 - 09/2011
2	TensinsIBA 06/2013 - 02/2013
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 06/2013 - 02/2013
2	Serine (L-Serine)FDA Link 02/2013 - 11/2006
2	Phosphotransferases (Kinase)IBA 07/2008 - 02/2006
2	Hepatocyte Nuclear Factor 3-betaIBA 07/2008 - 06/2004
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2006 - 08/2005
2	CCAAT-Enhancer-Binding Protein-betaIBA 07/2006 - 11/2003
2	anilinoquinazolineIBA 08/2005 - 02/2005
1	TubulinIBA 03/2024
1	Small Molecule LibrariesIBA 01/2024
1	Apolipoprotein E4IBA 11/2023
1	AcetyltransferasesIBA 06/2023
1	Phosphatidylinositols (Phosphatidylinositol)IBA 10/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2022
1	Cell Adhesion MoleculesIBA 01/2021
1	CalciumIBA 01/2021
1	Cadherins (E-Cadherin)IBA 01/2021
1	Neutralizing AntibodiesIBA 10/2020
1	Immunoglobulin G (IgG)IBA 10/2020
1	Deubiquitinating EnzymesIBA 01/2020
1	Excipients (Suspending Agents)IBA 01/2020
1	Heme (Haem)IBA 01/2020
1	HemopexinIBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 12/2019
1	OligomycinsIBA 12/2019
1	Sorafenib (BAY 43-9006)FDA Link 12/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	Enhancer RNAsIBA 01/2019
1	Untranslated RNA (Noncoding RNA)IBA 01/2019
1	CholesterolIBA 01/2019
1	Small Cytoplasmic RNAIBA 01/2019

Therapy/Procedure

16	Therapeutics 07/2023 - 08/2002
2	Aftercare (After-Treatment) 01/2022 - 10/2020
2	Transplantation 10/2014 - 08/2012
1	Hematopoietic Stem Cell Transplantation 10/2021
1	Immunotherapy 01/2021
1	Radiotherapy 01/2020
1	Injections 12/2019